ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Biomedical Engineering
SJR: 0.207 SNIP: 0.376 CiteScore™: 0.79

ISSN 印刷: 0278-940X
ISSN オンライン: 1943-619X

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.2014010464
pages 405-424

Has Percutaneous Aortic Valve Replacement Taken Center Stage in the Treatment of Aortic Valve Disease?

Gideon Praveen Kumar
Institute of High Performance Computing, A*STAR, Singapore
Fangsen Cui
Institute of High Performance Computing, A*STAR, Singapore
Lazar Mathew
Nanotech Research Facility, PSG Institute of Advanced Studies, Tamil Nadu, India
Hwa Liang Leo
Department of Biomedical Engineering, National University of Singapore, Singapore

要約

Modern biomedical advances have propelled percutaneous valve replacement into an effective and powerful therapy for many heart valve diseases, especially aortic valve stenosis. Experiences so far suggest that outcomes for new percutaneous valve replacement surgery compare favorably with that of traditional valve surgery in selected patients with severe symptomatic aortic stenosis. The inception of percutaneous aortic valve replacement (PAVR) began in 1992 when the potential for treating valve diseases was demonstrated through a modern technique of endoluminal deployment of a catheter-mounted crimped stented heart valve in an animal model. The first successful demonstration of such novel technique of surgical replacement of a heart valve was performed in 2002, when valve implantation in a patient with aortic stenosis was reported. Despite initial stumbles and a perception of being an uphill task, PAVR has emerged as one of the breakthroughs in surgical procedures. More than 1500 citations were found in PubMed, half of which were available after 2011. This is primarily because more than 50,000 procedures are being performed in more than 40 countries wordwide, with encouraging outcomes, and several stented valves have been launched in the market. This review provides a detailed analysis of the current state of the art of PAVR. Moreover, a competitive landscape of various devices available in the market and their design considerations, biomaterial selections, and overall hemodynamic performance are presented.


Articles with similar content:

Abstract of "Is Euthanasia a Problem for Ayurveda"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Sreekumar Nellickapilly, Sudarsan Padmanabhan
Ethical Issues in Replacing a Periodontally Involved Tooth with Dental Implants: Thoughts, Beliefs, and Evidence
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.2, 2011, issue 2
Liran Levin
Cardiac Tumors: A Current Clinical and Pathological Perspective
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 4
Romeo A. Majano-Lainez
Current State of Immunosuppression: Past, Present, and Future
Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 2
Ravinder K. Wali, Sabine Karam
Rhinoplasty
Journal of Long-Term Effects of Medical Implants, Vol.13, 2003, issue 3
Daniel G. Becker